Basal cell adenocarcinoma of the parotid gland: prognostic factors and survival outcomes: a systematic review and pooled patient-level analysis
Francesco Chiari, Cecilia Dalmazzini, Matteo Fermi, Livio Presutti, Claudio Donadio Caporale, Pierre Guarino · 2026
Read Basal cell adenocarcinoma of the parotid gland: prognostic factors and survival outcomes: a systematic review and pooled patient-level analysis by Francesco Chiari, Cecilia Dalmazzini, Matteo Fermi, Livio Presutti, Claudio Donadio Caporale, Pierre Guarino (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13614973.txt.
Description
A rare, slow cancer of the parotid saliva gland has too few cases for trials, so pooled case data carry the evidence. Francesco Chiari and co-authors gathered sixty-eight patients from twenty-three studies spanning nineteen ninety to twenty twenty-five. The average age at diagnosis was about fifty-nine. Five-year disease-free survival reached about eighty-four percent, and disease-specific survival about ninety-three percent. About thirty-one percent of tumors came back, mostly at the first site.
Missing extra therapy after surgery and tumor growth along nerves each cut disease-free time. Positive cut edges hurt disease-specific survival. Late returns past five years are on record, so long follow-up is advised. The pooled numbers give surgeons firmer ground for advising patients.
Catalog record
| CREATOR | Francesco Chiari, Cecilia Dalmazzini, Matteo Fermi, Livio Presutti, Claudio Donadio Caporale, Pierre Guarino |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |